NM_001349232.2:c.2080-45284A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001349232.2(ATG7):c.2080-45284A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.732 in 151,936 control chromosomes in the GnomAD database, including 41,636 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.73 ( 41636 hom., cov: 31)
Consequence
ATG7
NM_001349232.2 intron
NM_001349232.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.583
Publications
5 publications found
Genes affected
ATG7 (HGNC:16935): (autophagy related 7) This gene encodes an E1-like activating enzyme that is essential for autophagy and cytoplasmic to vacuole transport. The encoded protein is also thought to modulate p53-dependent cell cycle pathways during prolonged metabolic stress. It has been associated with multiple functions, including axon membrane trafficking, axonal homeostasis, mitophagy, adipose differentiation, and hematopoietic stem cell maintenance. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]
ATG7 Gene-Disease associations (from GenCC):
- spinocerebellar ataxia, autosomal recessive 31Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.951 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATG7 | NM_001349232.2 | c.2080-45284A>G | intron_variant | Intron 20 of 20 | ENST00000693202.1 | NP_001336161.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.732 AC: 111135AN: 151818Hom.: 41596 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
111135
AN:
151818
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.732 AC: 111235AN: 151936Hom.: 41636 Cov.: 31 AF XY: 0.740 AC XY: 54980AN XY: 74290 show subpopulations
GnomAD4 genome
AF:
AC:
111235
AN:
151936
Hom.:
Cov.:
31
AF XY:
AC XY:
54980
AN XY:
74290
show subpopulations
African (AFR)
AF:
AC:
23813
AN:
41360
American (AMR)
AF:
AC:
11990
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
AC:
2381
AN:
3470
East Asian (EAS)
AF:
AC:
5043
AN:
5182
South Asian (SAS)
AF:
AC:
4124
AN:
4824
European-Finnish (FIN)
AF:
AC:
9187
AN:
10574
Middle Eastern (MID)
AF:
AC:
205
AN:
294
European-Non Finnish (NFE)
AF:
AC:
52403
AN:
67964
Other (OTH)
AF:
AC:
1548
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1440
2880
4320
5760
7200
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
840
1680
2520
3360
4200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3005
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.